CLINICAL SPECTRUM OF SULFONYLUREA OVERDOSE AND EXPERIENCE WITH DIAZOXIDE THERAPY

被引:39
作者
PALATNICK, W
MEATHERALL, RC
TENENBEIN, M
机构
[1] UNIV MANITOBA,DEPT FAMILY MED,WINNIPEG R3T 2N2,MANITOBA,CANADA
[2] UNIV MANITOBA,DEPT PEDIAT,WINNIPEG R3T 2N2,MANITOBA,CANADA
[3] UNIV MANITOBA,DEPT PHARMACOL,WINNIPEG R3T 2N2,MANITOBA,CANADA
[4] ST BONIFACE GEN HOSP,DEPT CLIN CHEM,WINNIPEG R2H 2A6,MANITOBA,CANADA
[5] MANITOBA POISON CONTROL CTR,WINNIPEG,MANITOBA,CANADA
关键词
D O I
10.1001/archinte.151.9.1859
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We retrospectively reviewed our 10-year experience with the management of sulfonylurea overdose. There were 40 overdoses in 37 patients aged 1 to 78 years, with two deaths and one patient being left in a chronic vegetative state. Blood sugar levels ranged from normal to severe recalcitrant hypoglycemia. Maximal duration of recurrent hypoglycemia was 82 hours. In 21 of 31 patients with hypoglycemia, response to hypertonic glucose therapy was poor, resulting in recurrent hypoglycemia. Six of these patients were treated with intravenous diazoxide and had prompt correction. Overdose of sulfonylurea drugs may produce severe, protracted hypoglycemia poorly responsive to hypertonic glucose therapy. Treatment with diazoxide is rational and effective and may be lifesaving.
引用
收藏
页码:1859 / 1862
页数:4
相关论文
共 15 条